Literature DB >> 26343001

Comparison of 5 monoclonal antibodies for immunopurification of human butyrylcholinesterase on Dynabeads: KD values, binding pairs, and amino acid sequences.

Hong Peng1, Stephen Brimijoin2, Anna Hrabovska3, Katarina Targosova4, Eric Krejci5, Thomas A Blake6, Rudolph C Johnson7, Patrick Masson8, Oksana Lockridge9.   

Abstract

Human butyrylcholinesterase (HuBChE) is a stoichiometric bioscavenger of nerve agents and organophosphorus pesticides. Mass spectrometry methods detect stable nerve agent adducts on the active site serine of HuBChE. The first step in sample preparation is immunopurification of HuBChE from plasma. Our goal was to identify monoclonal antibodies that could be used to immunopurify HuBChE on Dynabeads Protein G. Mouse anti-HuBChE monoclonal antibodies were obtained in the form of ascites fluid, dead hybridoma cells stored frozen at -80 °C for 30 years, or recently frozen hybridoma cells. RNA from 4 hybridoma cell lines was amplified by PCR for determination of their nucleotide and amino acid sequences. Full-length light and heavy chains were expressed, and the antibodies purified from culture medium. A fifth monoclonal was purchased. The 5 monoclonal antibodies were compared for ability to capture HuBChE from human plasma on Dynabeads Protein G. In addition, they were evaluated for binding affinity by Biacore and ELISA. Epitope mapping by pairing analysis was performed on the Octet Red96 instrument. The 5 monoclonal antibodies, B2 12-1, B2 18-5, 3E8, mAb2, and 11D8, had similar KD values of 10(-9) M for HuBChE. Monoclonal B2 18-5 outperformed the others in the Dynabeads Protein G assay where it captured 97% of the HuBChE in 0.5 ml plasma. Pairing analysis showed that 3E8 and B2 12-1 share the same epitope, 11D8 and B2 18-5 share the same epitope, but mAb2 and B2 12-1 or mAb2 and 3E8 bind to different epitopes on HuBChE. B2 18-5 was selected for establishment of a stable CHO cell line for production of mouse anti-HuBChE monoclonal.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biacore; Butyrylcholinesterase; Dynabeads; ELISA; Monoclonal antibody; Octet

Mesh:

Substances:

Year:  2015        PMID: 26343001      PMCID: PMC5095618          DOI: 10.1016/j.cbi.2015.08.024

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  25 in total

1.  Determination of antibody affinity by ELISA. Theory.

Authors:  S A Bobrovnik
Journal:  J Biochem Biophys Methods       Date:  2003-09-30

2.  Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.

Authors:  Melissa D Carter; Brian S Crow; Brooke G Pantazides; Caroline M Watson; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  Anal Chem       Date:  2013-11-08       Impact factor: 6.986

3.  Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum.

Authors:  Jennifer L S Sporty; Sharon W Lemire; Edward M Jakubowski; Julie A Renner; Ronald A Evans; Robert F Williams; Jurgen G Schmidt; Marcel J van der Schans; Daan Noort; Rudolph C Johnson
Journal:  Anal Chem       Date:  2010-08-01       Impact factor: 6.986

4.  Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.

Authors:  Lawrence M Schopfer; Oksana Lockridge; Stephen Brimijoin
Journal:  Gen Comp Endocrinol       Date:  2015-06-12       Impact factor: 2.822

5.  Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.

Authors:  Ashima Saxena; Wei Sun; James M Fedorko; Irwin Koplovitz; Bhupendra P Doctor
Journal:  Biochem Pharmacol       Date:  2010-09-21       Impact factor: 5.858

6.  Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose.

Authors:  Bin Li; Ivan Ricordel; Lawrence M Schopfer; Frédéric Baud; Bruno Mégarbane; Patrick Masson; Oksana Lockridge
Journal:  J Appl Toxicol       Date:  2010-08       Impact factor: 3.446

7.  Production and characterization of separate monoclonal antibodies to human acetylcholinesterase and butyrylcholinesterase.

Authors:  S Brimijoin; K P Mintz; M C Alley
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

8.  Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.

Authors:  C A Broomfield; D M Maxwell; R P Solana; C A Castro; A V Finger; D E Lenz
Journal:  J Pharmacol Exp Ther       Date:  1991-11       Impact factor: 4.030

9.  New tools in diagnosis and biomonitoring of intoxications with organophosphorothioates: case studies with chlorpyrifos and diazinon.

Authors:  M J van der Schans; A G Hulst; D van der Riet-van Oeveren; D Noort; H P Benschop; Ch Dishovsky
Journal:  Chem Biol Interact       Date:  2012-11-01       Impact factor: 5.192

10.  A high-throughput diagnostic method for measuring human exposure to organophosphorus nerve agents.

Authors:  Jennifer S Knaack; Yingtao Zhou; Carter W Abney; Justin T Jacob; Samantha M Prezioso; Katelyn Hardy; Sharon W Lemire; Jerry Thomas; Rudolph C Johnson
Journal:  Anal Chem       Date:  2012-10-19       Impact factor: 6.986

View more
  10 in total

1.  Monoclonal antibodies to human butyrylcholinesterase reactive with butyrylcholinesterase in animal plasma.

Authors:  Hong Peng; Stephen Brimijoin; Anna Hrabovska; Eric Krejci; Thomas A Blake; Rudolph C Johnson; Patrick Masson; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2015-11-14       Impact factor: 5.192

2.  Characterization of butyrylcholinesterase in bovine serum.

Authors:  Alicia J Dafferner; Sofya Lushchekina; Patrick Masson; Gaoping Xiao; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2017-02-08       Impact factor: 5.192

3.  Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis.

Authors:  Geoffroy Napon; Alicia J Dafferner; Ashima Saxena; Oksana Lockridge
Journal:  Comp Med       Date:  2018-10-02       Impact factor: 0.982

4.  Characterization of butyrylcholinesterase from porcine milk.

Authors:  Ashima Saxena; Tatyana Belinskaya; Lawrence M Schopfer; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2018-06-15       Impact factor: 4.013

5.  Monoclonal Antibodies That Recognize Various Folding States of Pure Human Butyrylcholinesterase Can Immunopurify Butyrylcholinesterase from Human Plasma Stored at Elevated Temperatures.

Authors:  Hong Peng; Thomas A Blake; Rudolph C Johnson; Alicia J Dafferner; Stephen Brimijoin; Oksana Lockridge
Journal:  ACS Omega       Date:  2016-12-13

6.  Hupresin Retains Binding Capacity for Butyrylcholinesterase and Acetylcholinesterase after Sanitation with Sodium Hydroxide.

Authors:  Seda Onder; Emilie David; Ozden Tacal; Lawrence M Schopfer; Oksana Lockridge
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

7.  Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.

Authors:  Sofya V Lushchekina; Lawrence M Schopfer; Bella L Grigorenko; Alexander V Nemukhin; Sergei D Varfolomeev; Oksana Lockridge; Patrick Masson
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

8.  Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase.

Authors:  Seda Onder; Ozden Tacal; Oksana Lockridge
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

9.  The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.

Authors:  Lawrence M Schopfer; Hervé Delacour; Patrick Masson; Jacqueline Leroy; Eric Krejci; Oksana Lockridge
Journal:  Molecules       Date:  2017-06-29       Impact factor: 4.411

Review 10.  Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.

Authors:  Nura A Mohamed; Isra Marei; Sergio Crovella; Haissam Abou-Saleh
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.